Wei Yu

6.1k citations

132 papers · 4.2k indexed · h-index 34

Impact in

Hepatology top 2%
Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in ⓘ

Cancer Research 22
- MicroRNA in disease regulation 11
Urology 7

Co-authors: Marie Annick Buendia (4 shared papers)Christine Neuveut (6 shared papers)Charlotte Labalette (8 shared papers)Claire-Angélique Renard (6 shared papers)Marie‐Annick Buendia (12 shared papers)Jeanne Tran Van Nhieu (3 shared papers)Biaoyang Lin (11 shared papers)Claire Renard (2 shared papers)
Journals: Scientific Reports (4 papers)Frontiers in Oncology (4 papers)PLoS ONE (4 papers)Molecular and Cellular Biology (4 papers)Journal of Cancer (3 papers)
Partner nations: China United States France

In The Last Decade

Wei Yu

125 papers receiving 4.1k citations

Peers

Countries citing papers authored by Wei Yu

Since Specialization

Citations

This map shows the geographic impact of Wei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yu more than expected).

Fields of papers citing papers by Wei Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yu. The network helps show where Wei Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Yu Line = papers co-authored together Wei Yu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mechanisms of HBV-related hepatocarcinogenesis Journal of Hepatology ·Christine Neuveut, Wei Yu, Marie Annick Buendia	2010	335
2	Nuclear Accumulation of Mutated β-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell Proliferation American Journal Of Pathology ·Jeanne Tran Van Nhieu, Claire Renard, Wei Yu, Daniel Cherqui, Élie Serge Zafrani, Marie Annick Buendia	1999	251
3	Acetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction Molecular and Cellular Biology ·Laurence Lévy, Wei Yu, Charlotte Labalette, Yuanfei Wu, Claire-Angélique Renard, Marie Annick Buendia, Christine Neuveut	2004	181
4	O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy Frontiers in Oncology ·Wei Yu, Lili Zhang, Qichun Wei, Anwen Shao	2020	177
5	Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach PLoS Genetics ·Dong Ding, Xiaoyan Lou, Dasong Hua, Wei Yu, Lisha Li, Jun Wang, Feng Gao, Na Zhao, Guoping Ren, Lanjuan Li, Biaoyang Lin	2012	151
6	Identification of the elementary structural units of the DNA damage response Nature Communications ·Francesco Natale, Alexander Rapp, Wei Yu, Andreas Maiser, Hartmann Harz, A. Scholl, Stephan Grulich, Tobias Anton, David Hörl, Wei Chen, Marco Durante, G. Taucher-Scholz, Heinrich Leonhardt, M. Cristina Cardoso	2017	146
7	The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis BMC Genomics ·Xuefeng Fang, Jae‐Geun Yoon, Lisha Li, Wei Yu, Jiaofang Shao, Dasong Hua, Shu Zheng, Leroy Hood, David R. Goodlett, Gregory Foltz, Biaoyang Lin	2011	137
8	Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features Hepatology ·Wei Yu, Jeanne Tran Van Nhieu, Sylvie Prigent, Petcharin Srivatanakul, Pierre Tiollais, Marie-Annick Buendia	2002	127
9	Activation of β-catenin in epithelial and mesenchymal hepatoblastomas Oncogene ·Wei Yu, Monique Fabrè, Sophie Branchereau, Frederick Gauthier, Giorgio Perilongo, Marie-Annick Buendia	2000	126
10	Identification of the LIM Protein FHL2 as a Coactivator of β-Catenin Journal of Biological Chemistry ·Wei Yu, Claire-Angélique Renard, Charlotte Labalette, Yuanfei Wu, Laurence Lévy, Christine Neuveut, Xavier Prieur, Marc Flajolet, Sylvie Prigent, Marie‐Annick Buendia	2003	122
11	Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer Cancer Research ·Claire-Angélique Renard, Charlotte Labalette, Carolina Armengol, Delphine Cougot, Wei Yu, Stefano Cairo, Pascal Pineau, Christine Neuveut, Aurélien de Reyniès, Anne Dejean, Christine Perret, Marie‐Annick Buendia	2007	120
12	Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma Oncogene ·Pascal Pineau, Hisaki Nagai, Sylvie Prigent, Wei Yu, Gàbor Gyapay, Jean Weissenbach, Pierre Tiollais, Marie‐Annick Buendia, Anne Dejean	1999	99
13	Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and β-Catenin Molecular and Cellular Biology ·Charlotte Labalette, Claire-Angélique Renard, Christine Neuveut, Marie‐Annick Buendia, Wei Yu	2004	99
14	Inhibiting RRM2 to enhance the anticancer activity of chemotherapy Biomedicine & Pharmacotherapy ·Yaqiong Zhan, Lushun Jiang, Xuehang Jin, Shuaibing Ying, Zhe Wu, Li Wang, Wei Yu, Jiepeng Tong, Li Zhang, Yan Lou, Yunqing Qiu	2020	89
15	RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma PLoS ONE ·Qichao Huang, Biaoyang Lin, Han-Qiang Liu, Xi Ma, Fan Mo, Wei Yu, Lisha Li, Hongwei Li, Tian Tian, Dong Wu, Feng Shen, Jinliang Xing, Zhi‐Nan Chen	2011	86
16	SOX2 Targets Fibronectin 1 to Promote Cell Migration and Invasion in Ovarian Cancer: New Molecular Leads for Therapeutic Intervention OMICS A Journal of Integrative Biology ·Xiaoyan Lou, Xu Han, Chengmeng Jin, Wei Tian, Wei Yu, Dong Ding, Li‐Hua Cheng, Bingding Huang, Huawei Jiang, Biaoyang Lin	2013	77
17	Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination Cell Reports ·Chloé Lescale, Hélène Lenden Hasse, Andrew N. Blackford, Gabriel Balmus, Joy J. Bianchi, Wei Yu, Léa Bacoccina, Angélique Jarade, Christophe Clouin, Rohan Sivapalan, Bernardo Reina‐San‐Martin, Stephen P. Jackson, Ludovic Deriano	2016	62
18	UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance Journal of Cancer ·Chengmeng Jin, Wei Yu, Xiaoyan Lou, Fan Zhou, Xu Han, Na Zhao, Biaoyang Lin	2013	61
19	⁶⁸Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results Journal of Nuclear Medicine ·Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A. Gorin, Steven P. Rowe, Hua Zhu, Kun Yan, Zhi Yang	2020	61
20	Meta-analysis and transcriptome profiling reveal hub genes for soybean seed storage composition during seed development Plant Cell & Environment ·Zhaoming Qi, Zhanguo Zhang, Zhongyu Wang, Jingyao Yu, Hongtao Qin, Xinrui Mao, Hongwei Jiang, Dawei Xin, Zhengong Yin, Rongsheng Zhu, Chunyan Liu, Wei Yu, Zhenbang Hu, Xiaoxia Wu, Jun Liu, Qingshan Chen	2018	60

About Wei Yu

Wei Yu is a scholar working on Cancer Research, Urology, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 132 papers that have together received 4.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), RNA modifications and cancer (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers), Cancer-related gene regulation (12 papers), Wnt/β-catenin signaling in development and cancer (11 papers), MicroRNA in disease regulation (11 papers), Hepatitis B Virus Studies (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Hepatology (445 citations), Cancer Research (764 citations), Molecular Biology (2.5k citations), Oncology (829 citations) and Epidemiology (637 citations). Wei Yu has collaborated with scholars based in China, United States and France. Frequent co-authors include Marie Annick Buendia, Christine Neuveut, Charlotte Labalette, Claire-Angélique Renard, Marie‐Annick Buendia, Jeanne Tran Van Nhieu, Biaoyang Lin, Claire Renard, Laurence Lévy and Qichun Wei. Their work appears in journals such as Scientific Reports, Frontiers in Oncology, PLoS ONE, Molecular and Cellular Biology and Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact